Salgenx Unveils Revolutionary Saltwater Redox Flow Battery for Grid-Scale Energy Storage
Salgenx, a division of Infinity Turbine LLC, is proud to announce the launch of its groundbreaking saltwater redox flow battery, offering a sustainable and cost-effective alternative to traditional lithium-ion batteries for grid-scale energy storage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203440827/en/
Salgenx Grid Scale 3000 kWh MegaWatt Pack Battery (Photo: Business Wire)
Key Advantages of Salgenx's Saltwater Redox Flow Battery:
- Enhanced Safety: Utilizing non-flammable, non-toxic materials, the saltwater battery significantly reduces risks associated with thermal runaway and fires, ensuring safer operation compared to lithium-ion counterparts.
- Environmental Sustainability: Constructed from abundant and eco-friendly materials including biochar from bamboo, the battery minimizes environmental impact and simplifies recycling processes, promoting a circular economy approach.
- Cost-Effectiveness: The use of widely available resources leads to lower production costs, making it a financially viable solution for large-scale energy storage needs.
- Scalability and Durability: Designed for easy scalability, the battery can be expanded to meet growing energy demands. Its robust architecture ensures a long cycle life with deep discharge capabilities, providing reliable performance over time.
Innovative Applications:
Beyond energy storage, the Salgenx saltwater redox flow battery offers multifunctional capabilities, including:
- Desalination: Simultaneously produces fresh water during the charging process, addressing water scarcity issues.
- Thermal Storage: The benefit of a grid-scale flow battery is the ability to simultaneously store hot or cold water, making it a Thermal Energy Storage (TES) device. Each battery can hold up to 48,000 liters of liquid thermal energy.
These unique features position the Salgenx battery as a versatile solution for various industrial applications, enhancing its value proposition in the energy storage market.
Grid-Scale Capacity:
The Salgenx system is engineered for large-scale energy storage, making it ideal for utility companies and renewable energy integration. Its modular design allows for seamless expansion, catering to diverse energy requirements and contributing to grid stability and resilience.
About Salgenx:
Salgenx, a division of Infinity Turbine LLC, specializes in innovative energy storage solutions. Committed to sustainability and technological advancement, Salgenx develops cutting-edge products that address the evolving needs of the energy sector.
Saltwater Battery Website: https://salgenx.com
Infinity Turbine Website: https://www.infinityturbine.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203440827/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release
The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release
Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release
Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve
Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release
Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom